Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunocore Holdings Plc ADR (IMCR)

Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunocore Holdings Plc ADR 92 PARK DRIVE MILTON PARK ABINGDON OXFORDSHIRE X0 OX14 4RY GBR

www.immunocore.com P: 44-12-3543-8600

Description:

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 2,981,786
Enterprise Value, $K 2,587,166
Shares Outstanding, K 49,821
Annual Sales, $ 249,430 K
Annual Net Income, $ -55,290 K
Last Quarter Sales, $ 70,340 K
Last Quarter Net Income, $ -19,790 K
EBIT, $ -59,640 K
EBITDA, $ -55,550 K
60-Month Beta 0.92
% of Insider Shareholders 9.10%
% of Institutional Shareholders 84.50%
Float, K 45,287
% Float 90.90%
Short Volume Ratio 0.47

Growth:

1-Year Return -1.52%
3-Year Return 46.31%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 05/08/24
Latest Earnings Date N/A
Earnings Per Share ttm -1.16
EPS Growth vs. Prev Qtr -1,100.00%
EPS Growth vs. Prev Year 36.51%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.51%
Return-on-Assets % -10.32%
Profit Margin % -22.17%
Debt/Equity 0.13
Price/Sales 12.25
Price/Cash Flow N/A
Price/Book 8.23
Book Value/Share 7.42
Interest Coverage -10.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar